Latest filing published 12 Dec 2006 for CardioVascular BioTherapeutics, Inc., €8,280.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Daniel C. Montano: trading record in brief
Daniel C. Montano is a declared insider of CardioVascular BioTherapeutics, Inc., with filings sourced from SEC (Form 4). We count 24 filings; the first trade dates from 1 January 2000 and the latest from 12 December 2006.
The open-market record is one-sided, with 20 purchases worth €256k and not one sale. The totals do not cover 8 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. Since January 2006: 20 purchases and no sales on the market.
Half of the purchases are above €19k and half below.
The latest filing, published on 12 December 2006, reports an open-market purchase of €8,280 in CardioVascular BioTherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 8 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel C. Montano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.10Common StockSEC:0001303497-06-000047:0Canonical exit: 12 Mar 2007 (T+90)
- 30,000 shares@ US$1.10Common StockSEC:0001303497-06-000047:1Canonical exit: 12 Mar 2007 (T+90)
- 15,000 shares@ US$3.47Common StockSEC:0001303497-06-000041:0Canonical exit: 7 Nov 2006 (T+90)
- 4,630 shares@ US$4.30Common StockSEC:0001303497-06-000040:0
- 1 shares0Common StockSEC:0001303497-06-000027:0
- 00Common StockSEC:0001303497-06-000017:3Canonical exit: 31 Mar 2000 (T+90)
- 00Common StockSEC:0001303497-06-000017:4Canonical exit: 31 Mar 2000 (T+90)
- 00Common StockSEC:0001303497-06-000013:3Canonical exit: 31 Mar 2000 (T+90)
- 3,000 shares@ US$7.70Common StockSEC:0001303497-06-000013:0Canonical exit: 29 Jun 2006 (T+90)
- 3,000 shares@ US$7.758Common StockSEC:0001303497-06-000013:1Canonical exit: 29 Jun 2006 (T+90)
- 1,000 shares@ US$7.80Common StockSEC:0001303497-06-000013:2Canonical exit: 2 Jul 2006 (T+90)
- 00Common StockSEC:0001303497-06-000013:4Canonical exit: 2 Jul 2006 (T+90)
- 00Common StockSEC:0001303497-06-000010:1Canonical exit: 31 Mar 2000 (T+90)
- 00Common StockSEC:0001303497-06-000010:2Canonical exit: 31 Mar 2000 (T+90)
- 2,250 shares@ US$7.70Common StockSEC:0001303497-06-000010:0Canonical exit: 28 Jun 2006 (T+90)
- 00Common StockSEC:0001303497-06-000005:1
- 00Common StockSEC:0001303497-06-000005:2
- 7,750 shares@ US$7.34Common StockSEC:0001303497-06-000005:0Canonical exit: 25 Jun 2006 (T+90)
- 00Common StockSEC:0001303497-06-000004:1Canonical exit: 31 Mar 2000 (T+90)
- 00Common StockSEC:0001303497-06-000004:2Canonical exit: 31 Mar 2000 (T+90)
- 5,500 shares@ US$6.89Common StockSEC:0001303497-06-000004:0Canonical exit: 20 Jun 2006 (T+90)
21 of 21 declarations